Name: CRVS Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: CRVS, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does CRVS have?

Accepted Answer

Corvus Pharmaceuticals, Inc. (CRVS) has 3 SEC Form 4 filings (16 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Jun 15, 2026.

Question 2

When was the most recent SEC Form 4 filing for CRVS?

Accepted Answer

The most recent Form 4 filing for CRVS on Tracefour is dated Jun 15, 2026.

Question 3

What is the net insider flow at CRVS over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at CRVS have net bought $334K based on SEC Form 4 disclosures.

Question 4

What is the total insider buy and sell value at CRVS in the current window?

Accepted Answer

Inside the rolling window, insiders at CRVS bought $334K and sold $0 based on SEC Form 4 filings.

Question 5

Can I get alerts for CRVS insider trading?

Accepted Answer

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Corvus Pharmaceuticals, Inc. (CRVS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

						Source
Moore David ScottFirst filing	Director	Purchase	21,700	$250K	Jun 15	SEC ↗
MILLER RICHARD A MDFirst filing	President and CEO	Purchase	6,932	$83K	May 20	SEC ↗

CRVS

Related companies